Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome

Clinically relevant muscle wasting affects a substantial proportion of patients with Parkinson’s disease (PD), although its prevalence varies according to the diagnostic criteria applied. This condition accelerates disease progression, reduces quality of life, and is a poor prognostic indicator associated with increased disability and mortality. Despite its clinical relevance, the molecular mechanisms underlying muscle wasting remain underinvestigated and poorly understood, constituting an unmet clinical need. Currently, there is insufficient evidence to definitively establish PD-associated muscle wasting as true cachexia, a syndrome characterized by systemic inflammation and metabolic dysregulation. Moreover, distinguishing the contribution of age-related sarcopenia from PD-specific pathological mechanisms remains challenging. A deeper understanding of the pathways and molecular signals involved in PD-associated muscle wasting may lead to therapeutic strategies to improve patient outcomes. Given the multifactorial nature of PD muscle wasting—e.g., motor neuron degeneration, aging, oxidative stress, inflammation, protein degradation, mitochondrial dysfunction—our aim is to provide a comprehensive overview of the current data on the cellular, molecular, and systemic mechanisms involved in this process. We also identify emerging therapeutic targets that may help prevent, attenuate, or reverse muscle atrophy in PD. Understanding muscle–brain crosstalk may redefine PD as a systemic rather than neurodegenerative disorder.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-11-17
DOI
https://doi.org/10.3390/biom16111669
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome

Laura Cristina Ceafalan, Gisela F. Gaina, Elena Mihaela Dragnea, Emilia Manole et al.
2 links
Biomolecules
Muscle Physiology and Disorders
article

Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome

Laura Cristina Ceafalan, Gisela F. Gaina, Elena Mihaela Dragnea, Emilia Manole, Bogdan Ovidiu Popescu
article en

Abstract

Clinically relevant muscle wasting affects a substantial proportion of patients with Parkinson’s disease (PD), although its prevalence varies according to the diagnostic criteria applied. This condition accelerates disease progression, reduces quality of life, and is a poor prognostic indicator associated with increased disability and mortality. Despite its clinical relevance, the molecular mechanisms underlying muscle wasting remain underinvestigated and poorly understood, constituting an unmet clinical need. Currently, there is insufficient evidence to definitively establish PD-associated muscle wasting as true cachexia, a syndrome characterized by systemic inflammation and metabolic dysregulation. Moreover, distinguishing the contribution of age-related sarcopenia from PD-specific pathological mechanisms remains challenging. A deeper understanding of the pathways and molecular signals involved in PD-associated muscle wasting may lead to therapeutic strategies to improve patient outcomes. Given the multifactorial nature of PD muscle wasting—e.g., motor neuron degeneration, aging, oxidative stress, inflammation, protein degradation, mitochondrial dysfunction—our aim is to provide a comprehensive overview of the current data on the cellular, molecular, and systemic mechanisms involved in this process. We also identify emerging therapeutic targets that may help prevent, attenuate, or reverse muscle atrophy in PD. Understanding muscle–brain crosstalk may redefine PD as a systemic rather than neurodegenerative disorder.

BiomoleculesVol. 16(11)
Carol Davila University of Medicine and Pharmacy (RO), Institutul National Victor Babes (RO), Spitalul Clinic Colentina (RO)
Good health and well-being
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon